Working capital decreased 23.9%
Working capital changed -23.9% from the comparable as-filed period.
$184.8M→$140.6M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CBLL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents decreased 18.6%
Cash & equivalents changed -18.6% from the comparable as-filed period.
$40.1M→$32.7M3 prior comparisons
Free-cash-flow margin moved 997 bp lower
Free-cash-flow margin changed -997 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-35.87%→-45.84%2 prior comparisons
Operating cash-flow margin moved 1025 bp lower
Operating cash-flow margin changed -1025 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-35.53%→-45.78%2 prior comparisons
Current assets decreased 21.0%
Current assets changed -21.0% from the comparable as-filed period.
$199.8M→$157.8M3 prior comparisons
Total assets decreased 19.9%
Total assets changed -19.9% from the comparable as-filed period.
$207.7M→$166.3M3 prior comparisons
Working capital / assets moved 442 bp lower
Working capital / assets changed -442 basis points from the comparable as-filed period.
88.97%→84.55%3 prior comparisons
Capital expenditure decreased 76.1%
Capital expenditure changed -76.1% from the comparable as-filed period.
$71,000→$17,0003 prior comparisons
Current ratio decreased 31.0%
Current ratio changed -31.0% from the comparable as-filed period.
13.31→9.183 prior comparisons
Operating margin moved 58 bp lower
Operating margin changed -58 basis points from the comparable as-filed period.
-70.53%→-71.11%2 prior comparisons
Current liabilities increased 14.6%
Current liabilities changed +14.6% from the comparable as-filed period.
$15.0M→$17.2M3 prior comparisons
Inventory increased 12.3%
Inventory changed +12.3% from the comparable as-filed period.
$6.0M→$6.7M3 prior comparisons
Shares outstanding increased 4.7%
Shares outstanding changed +4.7% from the comparable as-filed period.
36,663,968→38,378,1013 prior comparisons
Capex / revenue moved 27 bp lower
Capex / revenue changed -27 basis points from the comparable as-filed period.
0.33%→0.06%2 prior comparisons
R&D / revenue moved 113 bp higher
R&D / revenue changed +113 basis points from the comparable as-filed period.
22.89%→24.01%2 prior comparisons
Receivables / revenue moved 115 bp lower
Receivables / revenue changed -115 basis points from the comparable as-filed period.
58.08%→56.93%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.